share_log

Biogen | 8-K: Biogen reports strong second quarter 2024 results and raises full year 2024 financial guidance; Second quarter 2024 total revenue of $2.5 billion, GAAP diluted EPS of $4.00 and Non-GAAP diluted EPS of $5.28

Biogen | 8-K: Biogen reports strong second quarter 2024 results and raises full year 2024 financial guidance; Second quarter 2024 total revenue of $2.5 billion, GAAP diluted EPS of $4.00 and Non-GAAP diluted EPS of $5.28

渤健公司 | 8-K:Biogen公布了强劲的2024年第二季度业绩,并上调了2024年全年财务指导;2024年第二季度总收入为25亿美元,GAAP摊薄后每股收益为4.00美元,非公认会计准则摊薄每股收益为5.28美元
美股SEC公告 ·  08/01 18:57
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息